Walpar Nutritions Ltd.

•

walparnutritions.comBSE: -NSE: WALPAR

Market Cap₹ 23 Cr.

Current Price

High / Low₹ 51 / 21

Stock P/E11.8

Book Value₹ 18

Price to Book2.65

Dividend Yield0.00 %

ROCE17.7 %

ROE12.0 %

Face Value₹ 10

Add ratio to table

ABOUT

AI Sector View

AI GENERATED

Healthcare

Buy

This stance relies on proxies and positioning because no direct pharma-export or healthcare operating series exists in the dataset. The depreciated currency at 95.23 (Sep/26) can support export earnings, inflation at 4.45% (Jul/26) is manageable for a defensive sector, and consumer spending remains large at INR 44743 billion (Jun/26). Strong FPI inflow of INR 10620 crore over 3 months to 2026-08-31 from INR -11381 crore in the prior 3 months adds a real sector-specific tailwind, but confidence stays capped because the fundamental drivers are indirect proxies.

Confidence

50%

View full sector analysis →

PROS

Company is almost debt free
Strong cash generation - operating cash flow backs reported profits (CFO/PAT 2.24x)
Company generates healthy free cash flow
Company converts assets efficiently - asset turnover of 2.2x

CONS

Receivables are growing faster than sales - a possible quality concern
Company has a low return on equity of 7.9% over last 3 years
Company has a low return on capital employed of 11.7%

* The pros and cons are machine generated based on quantitative rules.

Peer comparison

HealthcareHealthcarePharmaceuticals & Drugs

Part ofNIFTY 50 NIFTY 500 NIFTY LARGEMIDCAP 250 NIFTY 100 NIFTY 200

S.No.	Name
1.	SUNPHARMA	1933.00	38.34	463791.45	0.83	2901.23	26.53	15299.88	10.98	19.11	28.81
2.	DIVISLAB	9232.00	83.79	245080.59	0.33	902.00	65.50	3080.00	27.80	21.51	40.75
3.	TORNTPHARM	5004.40	87.28	190351.29	0.76	566.00	3.28	4921.00	57.32	19.27	33.81
4.	ZYDUSLIFE	1151.20	25.44	114832.64	0.09	990.20	-34.90	8017.00	23.97	21.39	24.54
5.	CIPLA	1413.15	33.87	114162.52	0.92	785.55	-39.18	7119.28	4.13	16.00	16.73
6.	LAURUSLABS	1863.00	92.06	100660.17	0.11	362.07	123.94	2026.31	29.10	18.20	31.50
7.	LUPIN	2152.60	17.80	98431.05	0.84	1416.98	16.01	8276.89	34.28	28.86	29.59
8.	MANKIND	2380.00	48.13	98304.73	0.04	574.09	29.12	4030.59	12.89	13.24	26.30
9.	DRREDDY	1161.00	30.07	96906.34	0.69	435.60	-69.10	8099.80	-5.21	13.75	10.63
10.	AUROPHARMA	1656.30	25.67	95299.84	0.24	1032.03	25.22	9150.35	17.44	12.76	20.54
11.	GLENMARK	2451.70	38.49	69193.02	0.10	482.83	927.88	4018.48	31.35	20.35	20.03
12.	WALPAR	24.70	9.38	23.19	0.00	—	—	—	—	17.78	—

Detailed Comparison with:

Quarterly Results

Standalone Figures in Rs. Crores / View Consolidated

No standalone quarterly results found

We don't have this information yet. Please check back later.

Profit & Loss

Standalone Figures in Rs. Crores / View Consolidated

	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025
	6	27	29	51	60
	6	26	28	50	57
Operating Profit	0	1	1	2	3
OPM %	8	4	4	4	5
Other Income	0	0	0	0	0
Interest	0	0	0	0	0
Depreciation	0	0	0	0	0
	0	0	0	1	2
Tax %	8	-25	36	25	30
Net Profit	0	0	0	1	2
EPS	0	1	1	2	2
Dividend Payout %	0	0	0	0	0
Minority Interest	0	0	0	0	0
Share of Associates	0	0	0	0	0
Adjusted EPS	0	0	0	1	2

COMPOUNDED SALES GROWTH

10 Years:: —
5 Years:: —
3 Years:: 31%

COMPOUNDED PROFIT GROWTH

10 Years:: —
5 Years:: —
3 Years:: 59%

STOCK PRICE CAGR

10 Years:: —
5 Years:: 8%
3 Years:: -19%
1 Year:: -44%

RETURN ON EQUITY

10 Years:: —
5 Years:: 6%
3 Years:: 8%
Last Year:: 12%

Balance Sheet

Standalone Figures in Rs. Crores / View Consolidated

	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025
LIABILITIES	-	-	-	-	-
Equity Capital	3	5	5	5	9
	1	6	7	9	6
	2	1	2	0	0
Trade Payables	5	7	7	8	14
	4	3	2	1	2
Total Liabilities	16	23	22	23	31
ASSETS	-	-	-	-	-
	1	1	1	1	2
	0	3	3	5	5
	4	6	6	5	5
	0	0	0	10	17
Cash & Bank	1	0	0	0	2
	9	13	12	2	1
Total Assets	16	23	22	23	31
Total Debt	5	4	3	0	0
Net Working Capital	5	6	7	7	8
Contingent Liabilities	0	0	0	0	0
Book Value per Share	13.70	24.20	24.85	28.36	15.98
Face Value	10.00	10.00	10.00	10.00	10.00

Cash Flows

Standalone Figures in Rs. Crores / View Consolidated

	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025
	1	-0	1	3	3
Cash from Investing	-1	-5	0	-1	-1
Cash from Financing	-0	4	-2	-2	-0
	1	-1	0	0	1
Free Cash Flow	1	-0	1	2	1
OCF / Net Profit	9.14	-0.76	3.71	2.82	1.60
Cumulative 5-Year FCF	0	0	0	0	0

Ratios

Standalone Figures in Rs. Crores / View Consolidated

	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025
PER SHARE
EPS (₹)	0.45	0.92	0.65	2.37	1.80
Book Value (₹)	13.70	24.20	24.85	28.36	15.98
Dividend per Share (₹)	0.00	0.00	0.00	0.00	0.00
Cash EPS (₹)	0.40	0.77	0.60	1.40	2.24
PROFITABILITY
Operating Margin %	7.60%	4.11%	3.66%	3.43%	4.73%
Net Margin %	2.48%	1.56%	1.03%	2.17%	2.81%
ROE %	3.29%	5.37%	2.64%	9.03%	11.95%
ROCE %	3.41%	6.44%	5.36%	11.98%	17.70%
	0.96%	2.15%	1.31%	4.93%	6.23%
EFFICIENCY
Debtor Days	430	111	114	67	82
Inventory Days	261	70	76	39	30
Payable Days	435	109	105	60	76
	256	72	84	46	36
FINANCIAL HEALTH
Debt to Equity (x)	1.19x	0.40x	0.28x	0.02x	0.00x
Interest Coverage (x)	1.92x	1.70x	2.34x	8.19x	25.01x
	1.66x	1.58x	1.70x	1.69x	1.50x
GROWTH
Revenue Growth %	0.00%	340.97%	7.27%	78.77%	17.24%
Operating Profit Growth %	0.00%	138.61%	-4.47%	79.85%	55.68%
Net Profit Growth %	0.00%	177.44%	-29.61%	277.61%	52.31%
	0.00%	0.00%	0.00%	265.21%	-23.85%
VALUATION
P/E (x)	0.00x	0.00x	0.00x	22.23x	23.47x
P/B (x)	0.00x	0.00x	0.00x	3.71x	2.65x
Dividend Yield %	0.00%	0.00%	0.00%	0.00%	0.00%
	0.00x	0.00x	0.00x	26.06x	12.98x

Shareholding Pattern

Numbers in percentages

	Sep 2022	Mar 2023	Sep 2023	Mar 2024	Sep 2024	Mar 2025	Sep 2025	Mar 2026
	70.58	70.54	71.46	71.23	68.44	68.52	68.61	68.82
FIIs	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
DIIs	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Government	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
	29.42	29.46	28.54	28.77	31.56	31.48	31.39	31.18

Documents

Corporate disclosures, annual reports, credit ratings, and concall transcripts

No announcements filed.

News

Recent coverage and analyst commentary for WALPAR

Loading news…

🤖

AI Stock Analyst

Walpar Nutritions Ltd.

🔒

Sign in to Chat with AI

✨ Sign In to Chat

Free 5nance Account

Name

SUNPHARMA

1933.00

38.34

463791.45

0.83

2901.23

26.53

15299.88

10.98

19.11

28.81

DIVISLAB

9232.00

83.79

245080.59

0.33

902.00

65.50

3080.00

27.80

21.51

40.75

TORNTPHARM

5004.40

87.28

190351.29

0.76

566.00

3.28

4921.00

57.32

19.27

33.81

ZYDUSLIFE

1151.20

25.44

114832.64

0.09

990.20

-34.90

8017.00

23.97

21.39

24.54

CIPLA

1413.15

33.87

114162.52

0.92

785.55

-39.18

7119.28

4.13

16.00

16.73

LAURUSLABS

1863.00

92.06

100660.17

0.11

362.07

123.94

2026.31

29.10

18.20

31.50

LUPIN

2152.60

17.80

98431.05

0.84

1416.98

16.01

8276.89

34.28

28.86

29.59

MANKIND

2380.00

48.13

98304.73

0.04

574.09

29.12

4030.59

12.89

13.24

26.30

DRREDDY

1161.00

30.07

96906.34

0.69

435.60

-69.10

8099.80

-5.21

13.75

10.63

AUROPHARMA

1656.30

25.67

95299.84

0.24

1032.03

25.22

9150.35

17.44

12.76

20.54

GLENMARK

2451.70

38.49

69193.02

0.10

482.83

927.88

4018.48

31.35

20.35

20.03

WALPAR

24.70

9.38

23.19

0.00

—

17.78

—

Mar 2021

Mar 2022

Mar 2023

Mar 2024

Mar 2025

Operating Profit

OPM %

Other Income

Interest

Depreciation

Tax %

-25

Net Profit

EPS

Dividend Payout %

Minority Interest

Share of Associates

Adjusted EPS

Mar 2021

Mar 2022

Mar 2023

Mar 2024

Mar 2025

LIABILITIES

Equity Capital

Trade Payables

Total Liabilities

ASSETS

Cash & Bank

Total Assets

Total Debt

Net Working Capital

Contingent Liabilities

Book Value per Share

13.70

24.20

24.85

28.36

15.98

Face Value

10.00

Mar 2021

Mar 2022

Mar 2023

Mar 2024

Mar 2025

-0

Cash from Investing

-1

-5

-1

Cash from Financing

-0

-2

-0

-1

Free Cash Flow

-0

OCF / Net Profit

9.14

-0.76

3.71

2.82

1.60

Cumulative 5-Year FCF

Mar 2021

Mar 2022

Mar 2023

Mar 2024

Mar 2025

PER SHARE

EPS (₹)

0.45

0.92

0.65

2.37

1.80

Book Value (₹)

13.70

24.20

24.85

28.36

15.98

Dividend per Share (₹)

0.00

Cash EPS (₹)

0.40

0.77

0.60

1.40

2.24

PROFITABILITY

Operating Margin %

7.60%

4.11%

3.66%

3.43%

4.73%

Net Margin %

2.48%

1.56%

1.03%

2.17%

2.81%

ROE %

3.29%

5.37%

2.64%

9.03%

11.95%

ROCE %

3.41%

6.44%

5.36%

11.98%

17.70%

0.96%

2.15%

1.31%

4.93%

6.23%

EFFICIENCY

Debtor Days

430

111

114

Inventory Days

261

Payable Days

435

109

105

256

FINANCIAL HEALTH

Debt to Equity (x)

1.19x

0.40x

0.28x

0.02x

0.00x

Interest Coverage (x)

1.92x

1.70x

2.34x

8.19x

25.01x

1.66x

1.58x

1.70x

1.69x

1.50x

GROWTH

Revenue Growth %

0.00%

340.97%

7.27%

78.77%

17.24%

Operating Profit Growth %

0.00%

138.61%

-4.47%

79.85%

55.68%

Net Profit Growth %

0.00%

177.44%

-29.61%

277.61%

52.31%

0.00%

265.21%

-23.85%

VALUATION

P/E (x)

0.00x

22.23x

23.47x

P/B (x)

0.00x

3.71x

2.65x

Dividend Yield %

0.00%

0.00x

26.06x

12.98x

Sep 2022

Mar 2023

Sep 2023

Mar 2024

Sep 2024

Mar 2025

Sep 2025

Mar 2026

70.58

70.54

71.46

71.23

68.44

68.52

68.61

68.82

FIIs

0.00

DIIs

0.00

Government

0.00

29.42

29.46

28.54

28.77

31.56

31.48

31.39

31.18

Walpar Nutritions Ltd.

AI Sector View

Peer comparison

Quarterly Results

Profit & Loss

Balance Sheet

Corporate actions

Cash Flows

Ratios

Shareholding Pattern

Documents

News

Sign in to Chat with AI

Walpar Nutritions Ltd.

AI Sector View

Peer comparison

Quarterly Results

Profit & Loss

Balance Sheet

Corporate actions

Cash Flows

Ratios

Shareholding Pattern

Documents

News

Sign in to Chat with AI